Report: NFL Tried to Influence NIH-Supported Concussion Study

A Congressional investigation indicates that the National Football League may have sought to steer millions of dollars in National Institutes of Health funding away from one of its critics.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, RON ALMOGAccording to a report authored by Democrats in the U.S. House of Representatives, officials at the National Football League (NFL) “improperly attempted to influence” how the National Institutes of Health (NIH) awarded funds to fuel research on traumatic brain injury. At issue is $16 million that was part of a $30 million supposedly no-strings-attached donation that the NFL made to the Foundation for the NIH (FNIH) that was supposed to fund research into concussion and other brain trauma in 2013.

In 2014, the NIH put out a call for proposals for the $16 million grant to study chronic traumatic encephalopathy, eventually selecting one from Boston University (BU) researcher Robert Stern. Now, in their report released Monday (May 23), Democrats on the House Committee on Energy and Commerce have alleged that NFL officials contacted the FNIH and voiced their displeasure with Stern—who had been openly critical of the league’s handling of head injury-related neuropsychological testing in prior lawsuits—having received the grant.

“There are many of us who have significant concerns re BU and their ability to be unbiased and collaborative,” Elliot Pellman, former chair of the NFL’s defunct mild traumatic brain injury committee and currently a medical administrator for the league, wrote in an email to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies